Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04050995
Other study ID # TCT 021
Secondary ID 167534
Status Recruiting
Phase
First received
Last updated
Start date April 1, 2022
Est. completion date January 1, 2026

Study information

Verified date November 2022
Source The Children's Trust, United Kingdom
Contact Jonathan W Pool, PhD
Phone 0044 (0)1223 695401
Email jonathan.pool1@aru.ac.uk
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Prolonged Disorders Of Consciousness (PDOC) include the Vegetative State (VS) and the Minimally Conscious State (MCS) that persist for longer than four weeks. This research seeks to evaluate the validity (accuracy), reliability, and clinical utility (usefulness to clinicians) of the children's version of the Music Therapy Assessment Tool for Awareness in Disorders of Consciousness (MATADOC). The paediatric version is called the Music therapy Sensory Instrument for Cognition, Consciousness and Awareness (MuSICCA). The MATADOC is known to be accurate in diagnosis and has been shown to be clinically useful when working with adults. However, currently, there are no equivalent measures that have been rigorously tested for working with children. Therefore, there is a significant need for a valid and reliable measure, especially when the consequences of misdiagnosis include insufficient care provision, unsuitable treatment programmes, poor identification of intentions to communicate, and insufficient evidence for making difficult decisions around withdrawal of hydration and nutrition. The study will invite participants aged 2-18 years, who the medical team suspect of having a PDOC, from various medical facilities in the UK, Ireland and other English-speaking countries. Parental/carer consent will be required for inclusion in the study. Data collection will occur over 3 years. Each participant will be involved once for a maximum of 7 assessment sessions (4 for the MuSICCA, 1 for the Coma Recovery Scale - Revised (CRS-R), 1 for the Coma/Near Coma Scale (CNC), and 1 for the Nociception Coma Scale Revised (NCS-R)). The MuSICCA assessment protocol involves presenting musical stimuli in three modalities (visual, auditory, and tactile). The participants will be instructed to respond to stimuli and commands. Sessions will be recorded using audio-visual equipment and physical responses will be noted on documentation. The information gained will inform diagnosis and treatment. The participants' behaviours will also be scored on the CRS-R (the gold standard for diagnosis of DOC in adults), the CNC and the NCS-R.


Description:

The null hypotheses are as follows: The MuSICCA is not a valid tool for use with children and young people with Disorders Of Consciousness (DOC). The MuSICCA is not a reliable tool for use with children and young people with DOC. The MuSICCA is not a clinical useful tool for use with children and young people with DOC. The design has been chosen to test the validity and reliability of the MuSICCA. It will involve carrying out the two measures and comparing their results against the current gold standard (the Coma Recovery Scale-Revised) and the Coma-Near Coma Scale. The design is influenced by previous validation studies of these measures conducted with adults. There will be no control group because this is not a Randomised Controlled Trial (RCT) and, therefore, no recruited participant will be deprived of the potential benefits of the measures. All participants will receive intervention through the administration of the protocols of the assessment measures. The study intends to recruit 80 participants. Recruitment will involve the following procedure. Medical/clinical teams at each site will identify potential participants according to the inclusion and exclusion criteria. The participants' families will be contacted to invite them to a meeting to discuss the research. It will be made clear that there will be no obligation to attend the meeting and their care or treatment will not be reduced or withdrawn if they decide not to be involved in the study. Interested families will be informed about the research project at this initial meeting. This information will be delivered verbally in person by the assessing clinicians and the families will be given a participant information sheet, which will contain all the information about the research so that the family can think in their own time about the decision to involve their child. The information given will include: 1)what will be carried out during the assessments, 2)how data will be recorded (observation recording sheets, video recording), 3)how the data will be stored, 4)what the data will be used for, and 5)what will be done with the data when the study has finished. The information sheet will also contain information about the families' right to withdraw their child from the study at any time without consequence. The families will also be given the opportunity to ask questions so that they are satisfied that they understand why the research is being conducted, what the research will involve, and the extent of their child's involvement in the study if recruited. Data collection will take place over a 3-year period at sites in the United Kingdom (UK), United States, and other English-speaking countries, e.g. Australia, Canada and New Zealand. The data will consist of hand scored forms of the assessment tools and audio-visual recordings of the MuSICCA sessions. These recordings will be used to test the reliability of the MuSICCA between assessors and between assessment sessions.The selection and allocation of video recordings of sessions for inter-rater reliability will be carried out to control for differences of experience between assessing clinicians. In order to eliminate researcher bias, data will be collated by the trained assessors from the treating clinical team, and statistical analysis will be undertaken by an independent statistician. In order to eliminate bias during data collection, there will be no interim data analysis and data collectors (clinicians) will not be able to discuss with each other the findings of their assessments until after the assessments have been completed and the results submitted to the research assistant. Clinical utility of the MuSICCA will be evaluated using a questionnaire for each family and each assessing clinician using the tool. After each MuSICCA report is submitted and feedback given to the families, assessing clinicians and families will be asked to complete a short questionnaire to assess the clinical utility of the MuSICCA. Data storage Raw data (score forms and video recordings) will be stored on a secure cloud-based system. Access to the data will be managed and authorised by the Chief Investigator. Data analysis will be carried out by an independent statistician.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date January 1, 2026
Est. primary completion date April 1, 2025
Accepts healthy volunteers No
Gender All
Age group 2 Years to 18 Years
Eligibility Inclusion Criteria: - Between 2-18 years of age - Assessed by the interdisciplinary team as having a disorder of consciousness - Be under active investigation for diagnosis of DOC Exclusion Criteria: - Known hearing impairments - Known profound visual impairments - Known musicogenic epilepsy - Seizure disorders that cause frequent and/or prolonged seizures - English not first language

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United Kingdom The Children's Trust Tadworth Surrey
United States Children's Healthcare of Atlanta Atlanta Georgia
United States Bethany Children's Health Centre Bethany Oklahoma

Sponsors (2)

Lead Sponsor Collaborator
The Children's Trust, United Kingdom Temple University

Countries where clinical trial is conducted

United States,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Music therapy Sensory Instrument for Cognition, Consciousness and Awareness Measure of awareness 2 weeks
Primary Coma Recovery Scale - Revised Diagnostic tool for disorders of consciousness 1 day
Secondary Coma Near Coma Scale Diagnostic tool for disorders of consciousness. Measuring wakefulness and awareness using sensory stimulation and ratings form responses.
It is a scale comprised of 11 items with ratings for responses (0, 2, 4; 0 representing higher level response and 4 representing no response). The total score is calculated by adding the ratings and dividing by the number of items scored. Lower numbers indicate greater awareness/consciousness. The ranges are as follows:
0.00-0.89 indicates NO COMA
0.90-2.00 indicates NEAR COMA
2.01-2.89 indicates MODERATE COMA
2.90-3.49 indicates MARKED COMA
3.50-4.00 indicates EXTREME COMA
1 day
Secondary Nociception Coma Scale Assessment tool for measuring responses to potentially painful care and/or stimulation of a potentially painful area. It is a scale comprised of 3 items (motor response, verbal response, and facial expression). Ratings consist of 0, 1, 2, 3, with higher ratings indicating higher level responses.The total score is calculated summing the subscores. The total score range is 0-9. A total score equal to or above 4 suggests the presence of pain. 1 day
See also
  Status Clinical Trial Phase
Completed NCT05954650 - Clinical Validity of the Minimally Conscious State "Plus" and "Minus"
Suspended NCT04244058 - Changes in Glutamatergic Neurotransmission of Severe TBI Patients Early Phase 1
Not yet recruiting NCT05833568 - Five-day 20-minute 10-Hz tACS in Patients With a Disorder of Consciousness N/A
Recruiting NCT05219331 - Hydrocephalus Treatment on Persistent Disorder of Consciousness N/A
Recruiting NCT05706831 - Music Intervention and Transcranial Electrical Stimulation for Neurological Diseases N/A
Completed NCT03114397 - Long-term Effect of tDCS in Patients With Disorders of Consciousness N/A
Active, not recruiting NCT03623828 - Treating Severe Brain-injured Patients With Apomorphine Phase 2
Active, not recruiting NCT05734183 - Multisensorial IMmersive Experiences (MIME) in Disorders of Consciousness N/A
Recruiting NCT05714215 - SECONDs' Italian Translation and Transcultural Validation
Completed NCT04035655 - Sub-study of the NEURODOC Project : Neurophysiological Evaluation of a Routine Care Open Label tDCS Session N/A
Active, not recruiting NCT05747170 - Olfactory Stimulation in Severe Brain Injury N/A
Active, not recruiting NCT03826407 - Development of a Point of Care System for Automated Coma Prognosis
Recruiting NCT03576248 - CONsciousness Transcranial Electric STimulation N/A
Recruiting NCT03611166 - Proteomics for Chronic Disorder of Consciousness
Recruiting NCT05382260 - Personal Music for Disorders of Consciousness N/A
Not yet recruiting NCT05820178 - tDCS and rTMS in Patients With Early Disorders of Consciousness N/A
Recruiting NCT05343507 - Ketamine to Treat Patients With Post-comatose Disorders of Consciousness Phase 2/Phase 3
Completed NCT05536921 - Eye Tracking Technology in the Diagnosis of Neurological Patients
Recruiting NCT05740735 - Emotional and Neutral Sounds for Neurophysiological Prognostic Assessment of Critically Ill Patients With a Disorder of Consciousness
Completed NCT02647996 - Functional Connectivity Measurement After Severe Traumatic Brain Injury